Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion

  title={Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion},
  author={Oleg Pisarenko and Vadim Z. Lankin and Galina G. Konovalova and Larisa Serebryakova and Valentin Shulzhenko and Alexander A. Timoshin and O. V. Tskitishvili and Yu. A. Pelogeykina and Irina Studneva},
  journal={Molecular and Cellular Biochemistry},
  pages={241 - 250}
Abstract This study investigated the effects of peptide apelin-12 (H-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH, A12) and its novel structural analog (H-(NαMe)Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Phe-OH, AI) on myocardial antioxidant enzyme activities, lipid peroxidation, and reactive oxygen species formation in ex vivo and in vivo models of myocardial ischemia/reperfusion (I/R) injury. Isolated working rat hearts were subjected to global ischemia and reperfusion. Infusion of 140… 
5-Hydroxydecanoate Abolishes Cardioprotective Effects of a Structural Analogue of Apelin-12 in Ischemia/Reperfusion Injury
Restoration of myocardial energy metabolism and sarcolemma integrity via activation of mitoKATP may be of critical importance for MA-induced protection against I/R injury.
Myocardial protection from ischemia/reperfusion injury by exogenous galanin fragment
Treatment with galanin G1 increased cell viability in a dose-dependent manner, inhibited cell apoptosis and excessive mitochondrial reactive oxygen species (ROS) production in response to oxidative stress in H9C2 cells, and may represent a promising treatment strategy for ischemic heart disease.
Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia/reperfusion injury
It is suggested that G peptide is effective in mitigating cardiac I/R injury, thereby providing a rationale for promising tool for the treatment of cardiovascular diseases.
Galanin/GalR1-3 system: A promising therapeutic target for myocardial ischemia/reperfusion injury.
Protective efficacy of dinitrosyl iron complexes with reduced glutathione in cardioplegia and reperfusion
DNIC-GS is a promising adjunct agent for metabolic and antioxidant protection of the heart during cardioplegic arrest and reperfusion with significantly improved recovery of coronary flow and cardiac function compared with control.
Apelin/APJ System: A Novel Therapeutic Target for Myocardial Ischemia/Reperfusion Injury.
How the mechanisms of the apelin/APJ system reverse MIRI in detail are discussed and elaborate on APJ agonists, which may be used for therapy of MIRi, are elaborate.


Effects of structural analogues of apelin-12 in acute myocardial infarction in rats
The structural analogue of apelin-12 [MeArg1, NLe10]-A12 may be a promising basis to create a new drug for the treatment of acute coronary syndrome.
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury
This is the first study to yield evidence that the adipocytokine, apelin, produces direct cardioprotective actions involving the RISK pathway and the MPTP.
Nitric oxide synthase mediates the apelin-induced improvement of myocardial postischemic metabolic and functional recovery
Analysis of metabolic and functional effects of a synthesized 12 C-terminal residue of apelin and NG-nitro-L-arginine methyl ester in isolated working rat hearts shows involvement of NOS-dependent mechanisms in cardioprotection afforded by apelin.
Apelin activates l-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas
Apelin-12 Improves Metabolic and Functional Recovery of Rat Heart after Global Ischemia
Improved cardiac dysfunction after I/R injury and less cell mem-brane damage induced by A-12 are associated with maintaining high energy phosphates, particularly ATP, in reperfused myocardium.
Apelin protects myocardial injury induced by isoproterenol in rats
Status of myocardial antioxidants in ischemia-reperfusion injury.
The effect of natural dicarbonyls on activity of antioxidant enzymes in vitro and in vivo
The increase of erythrocytes Cu,Zn-SOD activity in diabetic patients treated with metformin was higher than in ery Throcytes of diabetic patients subjected to traditional therapy, and this enzyme activity was also detected in patients with diabetes mellitus type 2 with carbohydrate metabolism impairments.